Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Inogen Inc INGN

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.


NDAQ:INGN - Post by User

Bullboard Posts
Next >>
Post by whytestockson Feb 15, 2024 3:00pm
44 Views
Post# 35882509

Competitor Exit A Boom For Respiratory Device-Focused Inogen

Competitor Exit A Boom For Respiratory Device-Focused Inogen
JUST IN: $INGN Competitor Exit A Boom For Respiratory Device-Focused Inogen, Earns Analyst Upgrade | BenzingaIn January,  Koninklijke Philips NV (NYSE:PHG) announced that it would stop selling new CPAP or BiPAP sleep therapy devices or other...INGN - Competitor Exit A Boom For Respiratory Device-Focused Inogen, Earns Analyst Upgrade | Benzinga

Bullboard Posts
Next >>